Related Experiment Video
Updated: Jun 8, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Prosthetic valve endocarditis in a multicenter registry of Chinese patients
Hee-Hwa Ho1, Chung-Wah Siu, Kai-Hang Yiu
1Cardiac Medical Unit, Grantham Hospital, Aberdeen, Hong Kong, China. hokai_wah@yahoo.com
Insights
Prosthetic valve endocarditis (PVE) in Chinese patients has a high mortality rate (28%), with severe heart failure being a key predictor of death. Relapse and late complications affect over 10% of survivors.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Innovation
Background:
- Prosthetic valve endocarditis (PVE) poses significant clinical challenges, particularly in Asian populations.
- Understanding the outcomes of PVE is crucial for optimizing patient management and treatment strategies.
Purpose of the Study:
- To evaluate the clinical outcomes, including mortality, need for surgery, and relapse rates, of PVE in Chinese patients.
- To identify predictors of hospital mortality in this specific patient cohort.
Main Methods:
- Retrospective analysis of 80 consecutive Chinese patients diagnosed with PVE between March 2000 and June 2007.
- Inclusion criteria: fulfillment of modified Duke criteria for PVE.
- Endpoints: hospital mortality, valve surgery requirement, and PVE relapse.
Main Results:
- The study included 80 patients (mean age 56 ± 13 years, predominantly male) with PVE, mostly involving mechanical prostheses (95%) and late-onset PVE (69%).
- High rates of hospital complications (61%) and overall hospital mortality (28%) were observed.
- Severe heart failure emerged as the sole independent predictor of hospital death on multivariate analysis.
Conclusions:
- PVE in Chinese patients is associated with substantial morbidity and mortality.
- Severe heart failure is a critical factor influencing survival in PVE patients.
- Long-term follow-up revealed significant rates of late complications and relapse, underscoring the need for vigilant monitoring.
Abstract:
We evaluated the clinical outcomes of prosthetic valve endocarditis in 2 major tertiary referral centers in Hong Kong. The study population comprised 80 consecutive Chinese patients who fulfilled the modified Duke criteria for prosthetic valve endocarditis from March 2000 to June 2007. The major clinical endpoints analyzed were hospital mortality, need for valve surgery, and relapse of prosthetic endocarditis. The mean age at presentation was 56 ± 13 years, with a slight male preponderance. There were 76 (95%) patients with involvement of a mechanical prosthesis; the majority (69%) had late prosthetic endocarditis. Major hospital complications occurred in 49 (61%) patients. The overall hospital mortality was 28% (22 patients). Thirty-four (42%) patients required valve surgery during index hospitalization, of whom 5 (15%) died due to uncontrolled sepsis. Factors associated with hospital mortality were older age at presentation, Staphylococcus aureus infection, embolic events, severe heart failure, valve surgery, and any major complication. On multivariate analysis, severe heart failure was the only independent predictor of hospital death. Among the 58 hospital survivors followed up for a mean of 48 ± 31 months, 6 (10%) developed late complications related to prosthetic valve endocarditis, with 5 documented cases of relapse.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
